Meth Trends and Quest Diagnostics Drug Testing Index 2011

QuestDiagosticsTV interviews in this video discuss U.S. worker drug use and findings from Quest Diagnostics annual report released in September. The Quest Diagnostics Drug Testing Index™ includes an analysis of methamphetamine positives based on more than 4.5 million urine specimens collected in 2010.

Barry Sample PhD
Director of Science & Technology, Quest Diagnostics Employer Solutions:

• "In the last year thousands of U.S. workers have tested positive for methamphetamine."
• "What the public and employers need to understand is that methamphetamine is a highly addictive stimulant drug."

Steven Shoptaw PhD
Professor and NIDA Funded Researcher, UCLA:

• "The importance of these data from Quest Diagnostics is that this is the largest sample of drug testing results from the workplace. One of the new things that came out of the data though is that there does appear to be an advancement into states where maybe it's not been such a problem before."
• "This is about brain disease. We need to look at our data, get smarter about making available to the people who need treatment, options that will help them meet their goals."
• "It makes great sense to me that we should do everything we can to stop people from trying this drug even once."
• "Once you have a positive result you have some information that lets you know that your employee's in trouble in some way."

John Senego
Adoptive father & author, My Three Sons: The Birth of a New Family

• "The immediate impact on an employer is that it's going to affect productivity in the workplace and so they have the right to be concerned about that and to test for that reason."

If you have questions or comments-- post below, e-mail us or send a message via Twitter @UCLASARx! We welcome your feedback! Thanks for tuning in.



Tags: meth statistics, meth trends, meth use data, methamphetamine, quest diagnostics, quest diagnostics drug testing index, steven shoptaw, ucla sarx, workplace drug testing